by Sperm count tests are medical devices used to examine semen and determine the concentration of sperm and detect abnormalities. Sperm count tests allow men to check fertility levels and identify potential problems that may be hindering conception. These tests aid in the diagnosis of male factor infertility issues like low sperm concentration, low sperm motility, and abnormalities in sperm morphology. The global sperm count test market is estimated to be valued at US$ 892.4 million in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The need for sperm count tests is rising due to the growing prevalence of male infertility worldwide. According to the World Health Organization (WHO), around 50% of infertility cases can be attributed to male factors. Lifestyle changes, increasing pollution levels, obesity, smoking, stress, and certain medical conditions are resulting in declining male fertility in many parts of the world. Sperm count tests allow men to check their fertility potential and seek medical help if any abnormalities are detected. The accuracy and reliability provided by modern sperm count testing kits coupled with advantages like quick results and ease of use at home are fueling the demand for these products.
Market key trends:
One of the main trends in the sperm count test market is technological advancements in testing techniques. Traditionally, manual microscopic methods were used for sperm analysis which required technical expertise and long processing times. However, new generation automated and digital sperm analyzers are gaining popularity. These systems offer accurate quantitative and qualitative semen analysis using advanced computer-assisted sperm analysis (CASA) technology. They provide extensive sperm profiling within a short time with minimal errors. Adoption of such automated systems is expected to drive the market growth over the forecast period. Another key trend is the growing adoption of home-use sperm test kits. Easy availability of ovulation and fertility monitoring kits for home use through online retail channels is positively impacting the sperm count test market.
Porter’s Analysis
Threat of new entrants: Low as it requires large investment and compliance with strict regulations for clinical testing.
Bargaining power of buyers: Moderate due to presence of several manufacturers. However, buyers have less bargaining power due to inelastic nature of product.
Bargaining power of suppliers: Moderate as raw material suppliers have established relationships with manufacturers. Supplier switching cost is low.
Threat of new substitutes: Low as sperm count test has no close substitute and is considered gold standard for evaluating male fertility issues.
Competitive rivalry: High due to presence of large number of players offering comparable products. Players differentiate based on accurate results, ease of use and integrated connectivity features.
Key Takeaways
The global sperm count test market size is expected to witness high growth over the forecast period.
The Asia Pacific region is projected to grow at the fastest pace during the forecast period due to rising male infertility rates, increasing healthcare expenditures and growing awareness.
The North American region currently dominates the market owing to established distribution channels, high diagnostic rates and frequent product launches. Major players are focusing on the European region for potential opportunities attributable to favourable reimbursement scenarios and supportive government initiatives for fertility management.
Key players
operating in the sperm count test market are Medical Electronic Systems, LLC, Hamilton Thorne, Inc., Microptic, Bioline Technologies, ANDROFERT, and other prominent players. These players are focusing on new launches and regulatory approvals to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
